Philips and Digital China Health launch tele-radiology services in China
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Digital China Health, the largest provider of cloud-based healthcare services in China, today announced the introduction of SHINEFLY – a tele-radiology application and services platform co-created by the two companies to meet the demands of China’s rapidly expanding healthcare system.
With SHINEFLY, Philips and Digital Health China offer a scalable, customizable cloud-based image management solution for remotely storing, retrieving, viewing and analyzing medical images. SHINEFLY will include advanced clinical applications for cardiology, neurology and oncology. These will be deployed as cloud-based tele-radiology services and will pioneer pay-per-use arrangements to reduce costs for healthcare institutions. SHINEFLY allows radiological images and associated patient information to be remotely viewed, analyzed and reported on by clinical experts anywhere in the country, so that patients can receive optimum treatment via their local hospital, wherever they are.
“Philips is committed to integrating and co-creating solutions that reflect local health market needs to deliver better healthcare experiences for doctors and patients at lower cost,” said Andy Ho, CEO Philips Greater China. “SHINEFLY, co-created with Digital China Health, is one of the fruits of this strategy in China. This highly innovative cloud-based solution will support clinicians with definitive diagnoses and facilitates the delivery of consistently high quality of care.”
Philips and Digital China Health launch tele-radiology services in China:
- Philips partners with Digital China Health to launch SHINEFLY [1] – a secure cloud-based platform for tele-radiology applications
- Collaboration between radiologists and clinicians at different locations, aided by Philips’ image, information and analysis tools, will help primary and remotely located hospitals in China to enhance the access and quality of care
[1] Commercially available in China only
